Tech Company Financing Transactions
RaNA Therapeutics Funding Round
RaNA Therapeutics closed a $51 million financing round on 1/6/2017. Investors included private investors.
Transaction Overview
Company Name
Announced On
1/6/2017
Transaction Type
Venture Equity
Amount
$50,999,987
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 25 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
200 Sidney St. 310
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Website
Email Address
Overview
RaNA Therapeutics is a biotechnology company using its proprietary RNA upregulation platform to discover and develop highly selective epigenetic modulators of gene expression. RaNA's technology upregulates the expression of desirable genes that can prevent or treat disease.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ronald Renaud
VP - Bus. Development
Brian Fenton
Browse more venture capital transactions:
Prev: 1/6/2017: ClearScholar venture capital transaction
Next: 1/6/2017: Reputation.com venture capital transaction
Share this article
News on VC Transactions
We do our best to report on every notable VC transaction. VC transactions on this site are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs